Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.

Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their d...

Full description

Bibliographic Details
Main Authors: Miguel Santibáñez, Roberto Garrastazu, Mario Ruiz-Nuñez, Jose Manuel Helguera, Sandra Arenal, Cristina Bonnardeux, Carlos León, Juan Luis García-Rivero
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4928940?pdf=render
id doaj-539cd5d4266a4a8a8dfdb4a8dd8acc4a
record_format Article
spelling doaj-539cd5d4266a4a8a8dfdb4a8dd8acc4a2020-11-24T22:21:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015872710.1371/journal.pone.0158727Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.Miguel SantibáñezRoberto GarrastazuMario Ruiz-NuñezJose Manuel HelgueraSandra ArenalCristina BonnardeuxCarlos LeónJuan Luis García-RiveroExacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients.This was a retrospective population-based cohort study. We selected 900 patients with confirmed COPD aged ≥35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission. We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1-4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year.Of the patients, 16.4% had ≥1 severe exacerbations, varying from 9.3% in mild GOLD grade 1 to 44% in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95% confidence interval [CI], 3.53-12.83) and mortality (adjusted OR, 7.63; 95%CI, 3.41-17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated.Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.http://europepmc.org/articles/PMC4928940?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Miguel Santibáñez
Roberto Garrastazu
Mario Ruiz-Nuñez
Jose Manuel Helguera
Sandra Arenal
Cristina Bonnardeux
Carlos León
Juan Luis García-Rivero
spellingShingle Miguel Santibáñez
Roberto Garrastazu
Mario Ruiz-Nuñez
Jose Manuel Helguera
Sandra Arenal
Cristina Bonnardeux
Carlos León
Juan Luis García-Rivero
Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
PLoS ONE
author_facet Miguel Santibáñez
Roberto Garrastazu
Mario Ruiz-Nuñez
Jose Manuel Helguera
Sandra Arenal
Cristina Bonnardeux
Carlos León
Juan Luis García-Rivero
author_sort Miguel Santibáñez
title Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
title_short Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
title_full Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
title_fullStr Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
title_full_unstemmed Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
title_sort predictors of hospitalized exacerbations and mortality in chronic obstructive pulmonary disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients.This was a retrospective population-based cohort study. We selected 900 patients with confirmed COPD aged ≥35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission. We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1-4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year.Of the patients, 16.4% had ≥1 severe exacerbations, varying from 9.3% in mild GOLD grade 1 to 44% in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95% confidence interval [CI], 3.53-12.83) and mortality (adjusted OR, 7.63; 95%CI, 3.41-17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated.Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.
url http://europepmc.org/articles/PMC4928940?pdf=render
work_keys_str_mv AT miguelsantibanez predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT robertogarrastazu predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT marioruiznunez predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT josemanuelhelguera predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT sandraarenal predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT cristinabonnardeux predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT carlosleon predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
AT juanluisgarciarivero predictorsofhospitalizedexacerbationsandmortalityinchronicobstructivepulmonarydisease
_version_ 1725770608336175104